TrialBMC cancer2015

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study.

Pilar Garcia-Alfonso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.